<code id='DB22061716'></code><style id='DB22061716'></style>
    • <acronym id='DB22061716'></acronym>
      <center id='DB22061716'><center id='DB22061716'><tfoot id='DB22061716'></tfoot></center><abbr id='DB22061716'><dir id='DB22061716'><tfoot id='DB22061716'></tfoot><noframes id='DB22061716'>

    • <optgroup id='DB22061716'><strike id='DB22061716'><sup id='DB22061716'></sup></strike><code id='DB22061716'></code></optgroup>
        1. <b id='DB22061716'><label id='DB22061716'><select id='DB22061716'><dt id='DB22061716'><span id='DB22061716'></span></dt></select></label></b><u id='DB22061716'></u>
          <i id='DB22061716'><strike id='DB22061716'><tt id='DB22061716'><pre id='DB22061716'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:5

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more
          In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug
          In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

          DarronCummings/APInasurprisemove,theFoodandDrugAdministrationhascalledforameetingofoutsideadvisersto

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Amylyx ALS drug failure raises questions and concerns

          Relyvrio,anALSdrugmadebyAmylyxPharmaceuticals,failedtobeatplaceboinakeyclinicaltrial.AmylyxPharmaceu